Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.
about
Thrombosis Associated with Viral HepatitisPreclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet countsPeripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy.Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia.Community-based cross-sectional study: the association of lipids with hepatitis C seropositivity and diabetes mellitus.Thrombocytopenia and bleeding in veterans with non-hepatitis C-related chronic liver disease.Thrombocytopenia represents a risk for deterioration of liver function after radiofrequency ablation in patients with hepatocellular carcinomaLiver disease as a cause of thrombocytopenia.Nontransfusional approach to increased platelet count in patients with cirrhosis and thrombocytopenia.Incident severe thrombocytopenia in veterans treated with pegylated interferon plus ribavirin for chronic hepatitis C infection.The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombocytopaenia: a retrospective chart review from five European countries.Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.Thrombocytopenia, Platelet Transfusion, and Outcome Following Liver Transplantation.Non-surgical contraindication for acute appendicitis with secondary thrombocytopenia: a case report.Determinants of platelet count are different in patients with compensated and decompensated cirrhosis.Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.Comparative efficacy and cost effectiveness of splenectomy and thrombopoietin prior to peginterferon and ribavirin therapy with compensatory cirrhosis associated with hepatitis C and thrombocytopenia.KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis.Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies.Transient Elastography for Spleen Stiffness Measurement in Patients With Cirrhosis: Role in Degree of Thrombocytopenia.Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia.Thrombocytopenia in chronic liver disease.From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.P selectins and immunological profiles in HCV and Schistosoma mansoni induced chronic liver diseaseEffect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients.Substance abuse, HIV-1 and hepatitisInhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease.Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection.Big spleens and hypersplenism: fix it or forget it?Prediction of esophageal variceal bleeding in B-viral liver cirrhosis using the P2/MS noninvasive index based on complete blood counts.Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model.Perioperative safety analysis of transcatheter arterial chemoembolization for hepatocellular carcinoma patients with preprocedural leukopenia or thrombocytopenia.Impaired Platelet Aggregation and Rebalanced Hemostasis in Patients with Chronic Hepatitis C Virus Infection.Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension?Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis.Platelet count manipulation and modification of global haemostasis tests in patients with chronic liver disease: almost there, almost there….Thrombocytopenia in patients with chronic liver disease: what's in a name?
P2860
Q26781784-01D84D7A-789E-4E31-95B2-4A467AC3BA8FQ33382190-4DF17E63-46A8-4D3E-BF78-0B344EC631FEQ33399240-E3AE8B4C-DDE7-426C-BBB6-40286511FE7AQ33400529-D765690B-E685-4FD7-8776-E4E31F810AE6Q33401584-E7E72D0C-89C0-4ED8-8090-165A2F28B24CQ33402027-E1191C02-5292-4E1A-996A-F6927A07737DQ33403528-42657F4D-10C2-47EA-A6CD-1127C7712D25Q33403977-037B7827-610F-425F-AFC5-9D099CFDB016Q33405472-C617F8DF-33D2-4652-8DFF-C405C02BD081Q33407950-6FC83B6A-9AF4-472C-8012-F5A1AEAD6B6FQ33414281-08298190-FA62-4E2E-A240-7EBE37993461Q33414386-F881F46E-9AE8-4A80-B70C-69D2A93A940EQ33414392-95D5B273-B81B-425F-B6A0-EBD22B91EA7BQ33418708-465F6D6A-D2E9-46D6-948C-87EA9AA2EAB4Q33418906-B08BBC6E-6676-419F-93C3-F3D51F5FE4E0Q33421085-8E177E50-70BC-44AA-B21F-882E98F67732Q33424074-2A3F69F4-20EF-414A-A6E9-05A51F3B49F4Q33427048-8511E9CA-D537-4CD7-9103-8AA14DA42E09Q33428399-F8982011-97BF-4D23-9C1B-EAAB659F087CQ33430704-8C1FB926-DBC7-45BA-AFBC-06875C33428EQ33430833-6A9A81F6-A304-4F40-BB63-889E7AEEEDB3Q33430951-BB73A1A5-607C-4EB5-AC9A-227D7D282CC7Q33433589-2954BCDC-7366-4F77-A5D1-5DAAC17FFED6Q33433774-CCD66BD1-B5BA-4510-B167-1B06072D53C3Q33436905-49881B00-52D1-4490-938C-0A2DD94D33E3Q33441627-C8791712-34A5-4109-852C-28F0F6463241Q33990741-9C299BA1-D400-4261-84C2-55C5F4FE6DB6Q34467312-7A3AE0C7-6772-46AF-AD0B-B3538CBFB93EQ37003023-571C0531-C799-47E5-8088-AFF55177AC18Q37387670-E12BC03B-9A37-470E-B87C-8EC84C6E4747Q37534731-641B0757-B7EE-4F46-83D0-3852EC057C93Q38259960-67FBF177-7A46-48AC-8667-F2CC77DEB467Q39551266-2864C6CE-6D77-4540-96F8-36745D6B0470Q39737270-5450FF0F-6EC4-43BA-85DB-F564283BB90EQ40091865-D00122A3-E01E-49CA-ABE1-80ED09434527Q40211125-6CBD8503-7E35-4C91-B57A-E6F7E6401405Q41846141-26F83808-F61C-49E2-9C9D-0D72A04A1B39Q42212445-B84595FE-AD9D-479E-93F1-CE9E8F255040Q46032135-95EE32C8-3A9A-4C96-887A-91CD2DB96972Q48592088-E4E55BBF-0F74-4792-A8B9-D9CEE4F05A5B
P2860
Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Review article: thrombocytopen ...... armacologic treatment options.
@ast
Review article: thrombocytopen ...... armacologic treatment options.
@en
type
label
Review article: thrombocytopen ...... armacologic treatment options.
@ast
Review article: thrombocytopen ...... armacologic treatment options.
@en
prefLabel
Review article: thrombocytopen ...... armacologic treatment options.
@ast
Review article: thrombocytopen ...... armacologic treatment options.
@en
P2860
P1476
Review article: thrombocytopen ...... armacologic treatment options.
@en
P2093
Giannini EG
P2860
P304
P356
10.1111/J.1365-2036.2006.02889.X
P407
P577
2006-04-01T00:00:00Z